康华生物：2025年前三季度净利润约1.89亿元

Group 1 - The core viewpoint of the article highlights the financial performance of Kanghua Biological in Q3 2025, showing a significant decline in revenue and net profit compared to the previous year [1] - The company's revenue for the first three quarters of 2025 is approximately 840 million yuan, representing a year-on-year decrease of 20.78% [1] - The net profit attributable to shareholders is about 189 million yuan, reflecting a year-on-year decrease of 53.41% [1] - The basic earnings per share stand at 1.4553 yuan, which is a decrease of 52.59% year-on-year [1] Group 2 - As of the report date, Kanghua Biological has a market capitalization of 10.2 billion yuan [2]